PROCF · Sofgen Pharma S.A. · Debt

$0.03 +0.00 (+0.00%) At close · Oct 15

Market Cap

$58.18M

2.33B

Volume · Oct 15 314.27K Avg daily vol (8 sessions) 39.94K

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balance	As of	Amount	Source
Borrowings	2024-12-31	USD 267,966,000	20-F filed 2026-03-16
Related accounting measures — not additional borrowing Carrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year. Noncurrent long-term borrowings USD 41,407,000 Short-term borrowings USD 226,559,000
Current debt instruments issued	2024-12-31	USD 164,000,000	20-F filed 2026-03-16
Lease liabilities	2024-12-31	USD 30,318,000	20-F filed 2026-03-16
Related accounting measures — not additional borrowing Carrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year. Current lease liabilities USD 6,528,000 Noncurrent lease liabilities USD 23,790,000

Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.

Key facts CIK 1863362 Visit website Investor relations